Correlation Between Neuronetics and OncoCyte Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuronetics and OncoCyte Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuronetics and OncoCyte Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuronetics and OncoCyte Corp, you can compare the effects of market volatilities on Neuronetics and OncoCyte Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuronetics with a short position of OncoCyte Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuronetics and OncoCyte Corp.

Diversification Opportunities for Neuronetics and OncoCyte Corp

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Neuronetics and OncoCyte is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Neuronetics and OncoCyte Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoCyte Corp and Neuronetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuronetics are associated (or correlated) with OncoCyte Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoCyte Corp has no effect on the direction of Neuronetics i.e., Neuronetics and OncoCyte Corp go up and down completely randomly.

Pair Corralation between Neuronetics and OncoCyte Corp

Given the investment horizon of 90 days Neuronetics is expected to generate 3.93 times more return on investment than OncoCyte Corp. However, Neuronetics is 3.93 times more volatile than OncoCyte Corp. It trades about 0.03 of its potential returns per unit of risk. OncoCyte Corp is currently generating about -0.16 per unit of risk. If you would invest  97.00  in Neuronetics on August 25, 2024 and sell it today you would lose (8.00) from holding Neuronetics or give up 8.25% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Neuronetics  vs.  OncoCyte Corp

 Performance 
       Timeline  
Neuronetics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Neuronetics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain forward indicators, Neuronetics displayed solid returns over the last few months and may actually be approaching a breakup point.
OncoCyte Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OncoCyte Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Neuronetics and OncoCyte Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuronetics and OncoCyte Corp

The main advantage of trading using opposite Neuronetics and OncoCyte Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuronetics position performs unexpectedly, OncoCyte Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoCyte Corp will offset losses from the drop in OncoCyte Corp's long position.
The idea behind Neuronetics and OncoCyte Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets